COMPLEX SURGICAL TREATMENT OF PATIENTS WITH WIDESPREAD DESTRUCTIVE PULMONARY TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE OF MYCOBACTERIA USING INTRAVENOUS IMMUNOGLOBULIN PENTAGLOBIN
45 patients with pulmonary multidrug-resistant pulmonary tuberculosis who had pulmonectomy in the early postoperative period, in combination with the continuation of chemotherapy and antibiotic therapy, administered intravenous immunoglobulin pentaglobin to prevent broncho-pulmonary complications. Complications in the form of empyema of the pleural cavity without fistula formation were observed in two people (4.4%), who successfully performed step-bystep operations of thoracostomy and thoracomyoplasty. In 45 patients from the comparison group, who were not administered in the early postoperative period, complications occurred more often (28.8%) and were more severe. The largest proportion among complications was attributed to the inconsistency of the stump of the main bronchus and the development of pleural empyema (46.7%), for the elimination of which stage operations were required. In 2 (13.3%) patients' progression of the tuberculosis process in a single lung started, which led to their death. The fatal outcome within the first week after the operation resulted in the postoperative pneumonia of the single lung in 3 of 4 patients. As a result, one third of patients (33.3%) with the most severe complications died within 1 month after the operation. Thus, the use of pentaglobin in the complex surgical treatment of patients with tuberculosis in the early postoperative period after pneumonectomy allowed significantly reducing the incidence of complications and avoiding deaths.